Objects
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations.
Odenthal, Cara, Simpson Jr, Steve, Coulthard, Alan, Ausimmune AusLong Investigator Groups,, Williams, David, Lechner-Scott, Jeannette, , , , , , , Oughton, Justin, , , van der Mei, Ingrid, Rose, Stephen, Fripp, Jurgen, Lucas, Robyn, Taylor, Bruce, Dear, Keith, Ponsonby, Anne-Louise. Wiley-Blackwell; 2017. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: a multicentre Australian cohort study.
Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit. Elsevier; 2020. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder.
Bustamante, Marta F., Morcillo-Suárez, Carlos, Sánchez, Antonio J., Urcelay, Elena, Alvarez-Lafuente, Roberto, Villar, Lusia M., Alvarez-Cermeño, Jose Carlos, Farré, Xavier, Lechner-Scott, Jeannette, Vandenbroeck, Koen, Rodríguez-Antigüedad, Alfredo, Drulovic, Jelena S., Malhotra, Sunny, Martinelli Boneschi, Filippo, Chan, Andrew, Oksenberg, Jorge, Navarro, Arcadi, Montalban, Xavier, Comabella, Manuel, Rio, Jordi, Leyva, Laura, Fernández, Oscar, Zettl, Uwe K., Killestein, Joep, Brassat, David, García-Merino, Juan Antonio. Wolters Klumer Health; 2015. Pharmacogenomic study in patients with multiple sclerosis: responders and nonresponders to IFN-ß.
Clarke, Laura, Bukhari, Wajih, McCombe, Pamela A., Sutton, Ian, Boggild, Mike, Brownlee, Wallace, Carroll, William M., Hodgkinson, Suzanne, Macdonell, Richard A.L., Mason, Deborah F., Pereira, Jennifer, Slee, Mark, O'Gorman, Cullen M., Das, Chandi, Henderson, APD, Kermode, AG, Lechner-Scott, Jeannette, Waters, P, Sun, J, Broadley, SA, Khalilidehkordi, Elham, Arnett, Simon, Woodhall, Mark, Prain, Kerri M., Parratt, John D.E., Barnett, Michael H., Marriott, Mark P.. Elsevier; 2022. Response to treatment in NMOSD: the Australasian experience.
ARM, Jameen, Ribbons, Karen, Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2019. Evaluation of MS related central fatigue using MR neuroimaging methods: scoping review.
Cox, Mathew B., Cairns, Murray J., ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., Carroll, Adam P., Moscovis, Sophia, Stewart, Graeme J., Broadley, Simon, Scott, Rodney J., Booth, David R., Lechner-Scott, Jeannette. Public Library of Science; 2010. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood.
Spelman, Tim, Ozakbas, Serkan, Soysal, Aysun, Kuhle, Jens, Sanchez-Menoyo, Jose Luis, Blanco Morgado, Yolanda, Spitaleri, Daniele L. A., van Pesch, Vincent, Horakova, Dana, Ampapa, Radek, Patti, Francesco, Macdonell, Richard, Alroughani, Raed, Al-Asmi, A, Gerlach, O, Oh, J, Altintas, A, Tundia, N, Wong, SL, Butzkueven, H, Terzi, Murat, Hodgkinson, Suzanne, Laureys, Guy, Kalincik, Tomas, Van Der Walt, Anneke, Yamout, Bassem, Lechner-Scott, Jeannette. Sage Publications; 2023. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Bateman, Grant A., Lechner-Scott, Jeannette, Copping, Ross, Moeskops, Christopher, Yap, Swee Leong. BioMed Central; 2017. Comparison of the sagittal sinus cross-sectional area between patients with multiple sclerosis, hydrocephalus, intracranial hypertension and spontaneous intracranial hypotension: a surrogate marker of venous transmural pressure?.
Warrender-Sparkes, Matthew, Spelman, Tim, Alroughani, Raed, Iuliano, Gerardo, Duquette, Pierre, Girard, Marc, Terzi, Murat, Hupperts, Raymond, Grammond, Pierre, Petersen, Thor, Fernandez-Bolaños, Ricardo, Fiol, Marcela, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Trojano, Maria, Lugaresi, Alessandra, Grand'Maison, François, Havrdova, Eva, Horakova, Dana, Boz, Cavit, Oreja-Guevara, Celia. Sage; 2016. The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Arm, Jameen, Oeltzschner, Georg, Al-iedani, Oun, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2021. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.
Jokubaitis, Vilija G., Li, Vivien, Barnett, Michael, Grand'Maison, Francois, Trojano, Maria, Slee, Mark, Giuliani, Giorgio, Shaw, Cameron, Boz, Cavit, Spitaleri, Daniele L. A., Verheul, Freek, Haartsen, Jodi, Kalincik, Tomas, Liew, Danny, Butzkueven, Helmut, Izquierdo, Guillermo, Hodgkinson, Suzanne, Alroughani, Raed, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Duquette, Pierre, Girard, Marc. Lippincott Williams & Wilkins; 2014. Fingolimod after natalizumab and the risk of short-term relapse.
Cortes, Adrian, Field, Judith, Glazov, Evgeny A., Hadler, Johanna, ANZgene Consortium,, Stankovich, Jim, Brown, Matthew A., Lechner-Scott, Jeannette, Moscato, Pablo. Oxford University Press; 2013. Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Afzal, H. M. Rehan, Luo, Suhuai, Ramadan, Saadallah, Lechner-Scott, Jeannette. Sage; 2022. The emerging role of artificial intelligence in multiple sclerosis imaging.
Rhead, Brooke, Brorson, Ina S., Lea, Rodney A., Burnard, Sean, Maltby, Vicki E., Scott, Rodney J., Lechner-Scott, Jeannette, Harbo, Hanne F., Bos, Steffan D., Barcellos, Lisa F., Berge, Tone, Adams, Cameron, Quach, Hong, Moen, Stine Marit, Berg-Hansen, Pål, Celius, Elizabeth Gulowsen, Sangurdekar, Dipen P., Bronson, Paola G.. Public Library of Science; 2018. Increased DNA methylation of SLFN12 in CD4⁺ and CD8⁺ T cells from multiple sclerosis patients.
Maltby, Vicki E., Graves, Moira C., Lea, Rodney A., Benton, Miles C., Sanders, Katherine A., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2015. Genome-wide DNA methylation profiling of CD8+T cells shows a distinct epigenetic signature to CD4+T cells in multiple sclerosis patients.
Xavier, Alexandre, Campagna, Maria Pia, Lechner-Scott, Jeannette, Ausimmune Investigator Group,, Maltby, Vicki E., Kilpatrick, Trevor, Taylor, Bruce V., Butzkueven, Helmut, Ponsonby, Anne-Louise, Scott, Rodney J., Jokubaitis, Vilija G., Lea, Rodney A.. Frontiers Research Foundation; 2023. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.
Roos, Izanne, Diouf, Ibrahima, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Sharmin, Sifat, Ferraro, Diana, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamou, B, Altintas, A, Gerlach, O, van Pesch, V, Blanco, Y, Horakova, Dana, Maimone, D, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, McGuigan, C, Cartechini, E, Barnett, M, Hughes, S, Sa, MJ, Solaro, C, Havrdova, Eva Kubala, Ramo-Tello, C, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, Patti, Francesco, van der Walt, A, Butzkueven, H, Prevost, J, Sanchez-Menoyo, JL, Laureys, G, Gouider, R, Castillo-Triviño, T, Gray, O, Aguera-Morales, E, Al-Asmi, A, Shaygannejad, Vahid, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Moore, F, Malpas, C, Ozakbas, Serkan, Kalincik, T, Izquierdo, Guillermo, Eichau, Sara. Sage Publications Ltd.; 2023. Comparative effectiveness in multiple sclerosis: A methodological comparison.
Groen, Kira, Maltby, Vicki E., Sanders, Katherine A., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. Sage; 2016. Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology?.
Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco. BMJ Group; 2023. Disability accrual in primary and secondary progressive multiple sclerosis.
Spelman, Tim, Magyari, Melinda, Hyde, Robert, Duquette, Pierre, Lechner-Scott, Jeannette, Sajedi, Seyed Aidin, Lalive, Patrice, Shaygannejad, Vahid, Ozakbas, Serkan, Eichau, Sara, Alroughani, Raed, Terzi, Murat, Butzkueven, Helmut, Girard, Marc, Kalincik, T, Grand'Maison, F, Skibina, O, Khoury, SJ, Yamout, B, Sa, MJ, Gerlach, O, Blanco, Y, Karabudak, R, Van Der Walt, Anneke, Oreja-Guevara, C, Altintas, A, Hughes, S, Mccombe, P, Ampapa, R, de Gans, K, Mcguigan, C, Soysal, A, Prevost, J, John, N, Vukusic, Sandra, Inshasi, J, Stawiarz, L, Manouchehrinia, A, Forsberg, L, Sellebjerg, F, Glaser, A, Pontieri, L, Joensen, H, Rasmussen, PV, Sejbaek, T, Trojano, Maria, Poulsen, MB, Christensen, JR, Kant, M, Stilund, M, Mathiesen, H, Hillert, J, Iaffaldano, Pietro, Horáková, Dana, Drahota, Jiří, Pellegrini, Fabio. Frontiers Research Foundation; 2023. Predictors of treatment switching in the Big Multiple Sclerosis Data Network.
Giovannoni, Gavin, Hawkes, Christopher H., Lechner-Scott, Jeannette, Levy, Michael, Yeh, E. Ann. Elsevier; 2023. Is it ethical to use teriflunomide as an active comparator in phase 3 trials?.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2013. Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Australasian Medical Publishing Company Pty. Ltd.; 2015. A new era in the treatment of multiple sclerosis.
Monif, Mastura, Sequeira, Richard P., Maltby, Vicki E., Nguyen, Ai-Lan, Wesselingh, Robb, Seery, Nabil, Nesbitt, Cassie, Baker, Josephine, Dwyer, Chris, Taylor, Lisa, Rath, Louise, Van der Walt, Anneke, Muscat, Andrea, Marriott, Mark, Kalincik, Tomas, Lechner-Scott, Jeannette, O'Brien, Terence J., Butzkueven, Helmut, Stuckey, Sian, Sanfilippo, Paul G., Minh, Viet, Loftus, Naomi, Voo, Veronica, Fazzolari, Katherine, Moss, Melinda. Academic Press; 2024. CLADIN- CLADribine and INnate immune response in multiple sclerosis – A phase IV prospective study.
Lechner-Scott, Jeannette, Reeves, Penny, Ribbons, Karen, Saugbjerg, Bente, Lea, Rodney. CSIRO; 2021. Do people with multiple sclerosis receive appropriate support from the National Disability Insurance Scheme matching their level of disability? A description of disease 'burden and societal cost in people with multiple sclerosis in Australia' (BAC-MS).
Clarke, Laura, Arnett, Simon, Bundell, Christine S., Abernethy, David A., Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Bukhari, Wajih, Chen, Cella, Coulthard, A, Dale, RC, Das, C, Fabis-Pedrini, MJ, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Heshmat, S, Khalilidehkordi, Elham, Hodgkinson, S, Kilpatrick, TJ, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, Jeannette, Lin, M-W, Lynch, C, Macdonell, RAL, Mason, DF, Sanchez, Sofia Jimenez, McCombe, PA, Pereira, J, Pollard, JD, Ramanathan, S, Reddel, SW, Shaw, CP, Spies, JM, Stankovich, J, Sutton, I, Vucic, S, O'Gorman, Cullen, Walsh, M, Wong, RC, Yiu, EM, Barnett, MH, Kermode, AGK, Marriott, MP, Parratt, JDE, Slee, M, Taylor, B, Willoughby, E, Sun, Jing, Brilot, F, Vincent, A, Waters, P, Broadley, SA, Prain, Kerri M., Woodhall, Mark, Silvestrini, Roger. Frontiers Research Foundation; 2021. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Simpson-Yap, Steve, Maddox, Duncan, Reece, Jeanette, Lechner-Scott, Jeannette, Shaw, Cameron, Taylor, Bruce, Kalincik, Tomas, van der Walt, Anneke, Boggild, Mike. Elsevier; 2023. Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022.
Lechner-Scott, Jeannette, Agland, Susan, Allan, Michelle, Darby, David, Diamond, Keri, Merlo, Daniel, van der Walt, Anneke. Elsevier; 2023. Managing cognitive impairment and its impact in multiple sclerosis: An Australian multidisciplinary perspective.
Khormi, Ibrahim, Al-iedani, Oun, Casagranda, Stefano, Papageorgakis, Chirstos, Alshehri, Abdulaziz, Lea, Rodney, Liebig, Patrick, Ramadan, Saadallah, Lechner-Scott, Jeannette. Elsevier; 2023. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
Ma, Gerry Z. M., Stankovich, Jim, Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Danoy, Patrick, Foote, Simon J., Griffiths, Lyn, Heard, Robert N., Kermode, Allan G., Lechner-Scott, Jeannette, Moscato, Pablo, Kilpatrick, Trevor J., Perreau, Victoria M., Scott, Rodney J., Slee, Mark, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Stankovich, Jim, Binder, Michele D., Field, Judith, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L.. Public Library of Science; 2011. Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Kalincik, Tomas, Kister, Ilya, Ozakbas, Serkan, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Alroughani, Raed, Bacon, Tamar E., Terzi, Murat, Boz, C, Grand'Maison, F, Bergamaschi, R, Gerlach, O, Sa, MJ, Kappos, L, Cartechini, E, Lechner-Scott, Jeannette, van Pesch, V, Malpas, Charles B., Shaygannejad, V, Granella, F, Spitaleri, D, Iuliano, G, Maimone, D, Prevost, J, Soysal, A, Turkoglu, R, Ampapa, R, Butzkueven, H, Sharmin, Sifat, Cutter, G, for MSBase Study Group,, Horakova, Dana, Kubala-Havrdova, Eva, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara. Sage; 2022. Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Kalincik, Tomas, Brown, J. William L., McGuigan, Christopher, Jokubaitis, Vilija, Spelman, Tim, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Robertson, Neil, Lechner-Scott, Jeannette, , , , , , , , , , Willis, Mark, , , , , , , , , , , Scolding, Neil, , , , , , , , , , , Rice, Claire M., Wilkins, Alastair, Pearson, Owen, Ziemssen, Tjalf, Hutchinson, Michael. Lancet Publishing; 2017. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy.
Binder, Michele D., Fox, Andrew D., Laverick, Louise, Foo, Grace, Fabis-Pedrini, Marzena J., Spelman, Timothy, Jordan, Margaret A., Baxter, Alan G., Foote, Simon, , , , Merlo, Daniel, , , , , , , , , , Lechner-Scott, Jeannette, Johnson, Laura J., , , , , , Moscato, Pablo, Scott, Rodney, , , , Giuffrida, Sarah E., , Calvert, Rainer, Akkermann, Rainer, Ma, Gerry Z. M., Perera, Ashwyn A., Gresle, Melissa M.. Public Library of Science (PLoS); 2016. Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status.
Brochet, Bruno, Solari, Alessandra, Alexandri, Nektaria, Smyk, Andrzej, Nolting, Axel, Keller, Birgit, Montalban, Xavier, Kubala Havrdova, Eva, Lechner-Scott, Jeannette, Piehl, Fredrik, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Patti, Francesco, Brieva, Luis, Maida, Eva Maria. Sage; 2023. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study.
Diouf, Ibrahima, Malpas, Charles B., Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Ferraro, Diana, Sharmin, Sifat, Grammond, P, Yamout, B, Altintas, A, Gerlach, O, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Roos, Izanne, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Hodgkinson, S, Slee, M, Granella, F, de Gans, K, McCombe, PA, Ampapa, R, Horakova, Dana, van der Walt, A, Butzkueven, H, Sánchez-Menoyo, JL, Vucic, S, Laureys, G, Sidhom, Y, Gouider, R, Castillo-Trivino, T, Gray, O, Aguera-Morales, E, Kubala Havrdova, Eva, Al-Asmi, A, Shaw, C, Al-Harbi, TM, Csepany, T, Sempere, AP, Treviño Frenk, I, Stuart, EA, Kalincik, T, Patti, Francesco, Shaygannejad, Vahid, Ozakbas, Serkan, Eichau, Sara. British Medical Journals (BMJ); 2023. Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
Kister, Ilya, Spelman, Tim, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut, , Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre. B M J Group; 2016. Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Ahmad, Hasnat, van der Mei, Ingrid, Palmer, Andrew J., Taylor, Bruce V., Lucas, Robyn M., Ponsonby, Anne-Louise, Lechner-Scott, Jeannette, Dear, Keith, Valery, Patricia, Clarke, Philip M., Simpson, Steve. Sage; 2019. Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosis.
Diouf, Ibrahima, Malpas, Charles B., Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Sola, P, Ferraro, D, Grammond, P, Turkoglu, R, Buzzard, K, Skibina, O, Yamout, B, Altintas, A, Gerlach, O, Roos, Izanne, van Pesch, V, Blanco, Y, Maimone, D, Lechner-Scott, J, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Barnett, M, Horakova, Dana, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Ramo-Tello, C, Cristiano, E, Hodgkinson, S, Spitaleri, D, Soysal, A, Petersen, T, Havrdova, Eva Kubala, Slee, M, Butler, E, Granella, F, de Gans, K, McCombe, P, Ampapa, R, Van Wijmeersch, B, van der Walt, A, Butzkueven, H, Prevost, J, Patti, Francesco, Sinnige, LGF, Sanchez-Menoyo, JL, Vucic, S, Laureys, G, Van Hijfte, L, Khurana, D, Macdonell, R, Gouider, R, Castillo-Trivino, T, Gray, O, Shaygannejad, Vahid, Aguera-Morales, E, Al-Asmi, A, Shaw, C, Deri, N, Al-Harbi, T, Fragoso, Y, Csepany, T, Sempere, AP, Trevino-Frenk, I, Schepel, J, Ozakbas, Serkan, Moore, F, Kalincik, T, Izquierdo, Guillermo. Wiley-Blackwell; 2023. Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Gandhi, Kaushal S., McKay, Fiona C., Danoy, Patrick, Stewart, Graeme J., Broadley, Simon, Moscato, Pablo, Lechner-Scott, Jeannette, Scott, Rodney J., Booth, David R., ANZgene Multiple Sclerosis Genetics Consortium, Cox, Mathew, Riveros, Carlos, Armstrong, Nicola, Heard, Robert N., Vucic, Steve, Williams, David W., Stankovich, Jim, Brown, Matthhew. Oxford University Press; 2010. The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.
Bateman, Grant A., Bateman, Alexander R., Lechner-Scott, Jeannette. Elsevier; 2023. Dilatation of the bridging cerebral veins in multiple sclerosis correlates with fatigue and suggests an increase in pressure.
Kalincik, Tomas, Vivek, Vino, Bergamaschi, Roberto, Iuliano, Gerardo, Alroughani, Raed, Van Pesch, Vincent, Amato, Maria Pia, Slee, Mark, Verheul, Freek, Fernandez-Bolanos, Ricardo, Fiol, Marcela, La Spitaleri, Daniele, Jokubaitis, Vilija, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , , , , Trojano, Maria, , , , , , , , , , Izquierdo, Guillermo, Lugaresi, Alessandra, Grand’Maison, Francois, Hupperts, Raymond, Oreja-Guevara, Celia. Oxford University Press; 2013. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
Goris, An, Pauwels, Ine, D'Alfonso, Sandra, Barizzone, Nadia, Leone, Maurizio A., Boneschi, Filippo Martinelli, Sorosina, Melissa, Liberatore, Giuseppe, Kockum, Ingrid, Olsson, Tomas, Hillert, Jan, Alfredsson, Lars, Gustavsen, Marte W., Lechner-Scott, Jeannette, , , , , , , , , , van Son, Brechtje, , , , , , , , , , , Hilven, Kelly, , , , , , , , Bos, Steffan D., Celius, Elisabeth Gulowsen, Berg-Hansen, Pål, Aarseth, Jan, Myhr, Kjell-Morten. Oxford University Press; 2015. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
Harroud, Adil, Stridh, Pernilla, Andlauer, Till F. M., Ban, Maria, Barcellos, Lisa F., Barizzone, Nadia, Berge, Tone, Berthele, Achim, Bittner, Stefan, Bos, Steffan D., Briggs, Farren B. S., Caillier, Stacy J., McCauley, Jacob L., Calabresi, Peter A., Caputo, D, Carmona-Burgos, DX, Cavalla, P, Celius, EG, Cerono, G, Chinea, AR, Chitnis, T, Clarelli, F, Comabella, M, Saarela, Janna, Comi, G, Cotsapas, C, Cree, BCA, D’Alfonso, S, Dardiotis, E, De Jager, PL, Delgado, SR, Dubois, B, Engel, S, Esposito, F, van den Bosch, Aletta M. R., Fabis-Pedrini, MJ, Filippi, M, Fitzgerald, KC, Gasperi, C, Gomez, L, Gomez, R, Hadjigeorgiou, G, Hamann, J, Held, F, Henry, RG, Engelenburg, Hendrik J., Hillert, J, Huang, J, Huitinga, I, Islam, T, Isobe, N, Jagodic, M, Kermode, AG, Khalil, M, Kilpatrick, TJ, Konidari, I, Beecham, Ashley H., Kreft, KL, Lechner-Scott, Jeannette, Leone, M, Luessi, F, Malhotra, S, Manouchehrinia, A, Manrique, CP, Martinelli-Boneschi, F, Martinez, AC, Martinez-Maldonado, V, Alfredsson, Lars, Mascia, E, Metz, LM, Midaglia, L, Montalban, X, Oksenberg, JR, Olsson, T, Oturai, A, Pääkkönen, K, Parnell, GP, Patsopoulos, NA, Alikhani, Katayoun, Pericak-Vance, MA, Piehl, F, Rubio, JP, Santaniello, A, Santoro, S, Schaefer, C, Sellebjerg, F, Shams, H, Shchetynsky, K, Silva, C, Amezcua, Lilyana, Siokas, V, Søndergaard, HB, Sorosina, M, Taylor, B, Vandebergh, M, Vasileiou, ES, Vecchio, D, Voortman, MM, Weiner, HL, Wever, D. Nature Publishing Group; 2023. Locus for severity implicates CNS resilience in progression of multiple sclerosis.
Papageorgakis, Christos, Firippi, Eleni, Gy, Benoit, Boutelier, Timothé, Khormi, Ibrahim, Al-iedani, Oun, Lechner-Scott, Jeannette, Ramadan, Saadallah, Liebig, Patrick, Schuenke, Patrick, Zaiss, Moritz, Casagranda, Stefano. Elsevier; 2023. Fast WASABI post-processing: Access to rapid B0 and B1 correction in clinical routine for CEST MRI.
Alshehri, Abdulaziz, Al-iedani, Oun, Koussis, Nikitas, Khormi, Ibrahim, Lea, Rodney, Lechner-Scott, Jeannette, Ramadan, Saadallah. Sage; 2023. Stability of longitudinal DTI metrics in MS with treatment of injectables, fingolimod and dimethyl fumarate.
Liyanage, Ganesha, Trewin, Benjamin P., Buckland, Ali, Fok, Anthony, Barnett, Michael H., Reddel, Stephen W., Marignier, Romain, El Hajj, Aseel, Monif, Mastura, van der Walt, Anneke, Lechner-Scott, Jeannette, Kermode, Allan G., Lopez, Joseph A., Kalincik, T, Broadley, SA, Dale, RC, Ramanathan, S, Brilot, F, Andersen, Jane, Tea, Fiona, Merheb, Vera, Nguyen, Kristy, Lee, Fiona X. Z., Fabis-Pedrini, Marzena J., Zou, Alicia. BMJ Group; 2024. The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-Associated disease.
Collins, Christian D. E., Ivry, Ben, Bowen, James D., Cheng, Eric M., Dobson, Ruth, Goodin, Douglas S., Lechner-Scott, Jeannette, Kappos, Ludwig, Galea, Ian. Sage; 2015. A comparative analysis of patient-reported expanded disability status scale tools.
Xavier, Alexandre, Maltby, Vicki E., Jokubaitis, Vilija G., Kilpatrick, Trevor, Alfredsson, Lars, Jagodic, Maja, Ponsonby, Anne-Louise, Taylor, Bruce V., Scott, Rodney J., Lea, Rodney A., Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria Pia, Burnard, Sean M., Tegner, Jesper N., Slee, Mark, Butzkueven, Helmut, Kockum, Ingrid, Kular, Lara. MDPI AG; 2023. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
Parnell, Grant P., Gatt, Prudence N., Liddle, Christopher, Slee, Mark, Vucic, Steve, Stewart, Graeme J., Booth, David R., McKay, Fiona C., Schibeci, Stephen, Krupa, Malgorzata, Powell, Joseph E., Visscher, Peter M., Montgomery, Grant W., Lechner-Scott, Jeannette, Broadley, Simon. Sage Publications; 2014. Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Malpas, Charles B., Roos, Izanne, Havrdova, Eva Kubala, Izquierdo, Guillermo, Eichau, Sara, Hodgkinson, Suzanne, Grammond, Pierre, Lechner-Scott, Jeannette, Kalincik, Tomas, MSBase Study Group,, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Butzkueven, Helmut, Kappos, Ludwig, Patti, Francesco, Alroughani, Raed, Horakova, Dana. Springer; 2022. Multiple Sclerosis Relapses Following Cessation of Fingolimod.
Daruwalla, Cyrus, Shaygannejad, Vahid, Eichau, Sara, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem, Khoury, Samia J., Sajedi, Seyed Aidin, Turkoglu, Recai, Altintas, Ayse, Skibina, Olga, Ozakbas, Serkan, Buzzard, Katherine, Grammond, P, Karabudak, R, van der Walt, A, Butzkueven, H, Maimone, D, Lechner-Scott, Jeannette, Soysal, A, John, N, Prevost, J, Havrdova, Eva Kubala, Spitaleri, D, Ramo-Tello, C, Gerlach, O, Iuliano, G, Foschi, M, Ampapa, R, van Pesch, V, Barnett, M, Shalaby, N, D'hooghe, M, Horakova, Dana, Kuhle, J, Sa, MJ, Fabis-Pedrini, M, Kermode, A, Mrabet, S, Gouider, R, Hodgkinson, S, Laureys, G, Van Hijfte, L, Macdonell, R, Alroughani, Raed, Oreja-Guevara, C, Cristiano, E, McCombe, P, Sanchez-Menoyo, JL, Singhal, B, Blanco, Y, Hughes, S, Garber, J, Solaro, C, McGuigan, C, Boz, Cavit, Taylor, B, de Gans, K, Habek, M, Al-Asmi, A, Mihaela, S, Castillo Triviño, T, Al-Harbi, T, Rojas, JI, Gray, O, Khurana, D, Patti, Francesco, Van Wijmeersch, B, Grigoriadis, N, Inshasi, J, Oh, J, Aguera-Morales, E, Fragoso, Y, Moore, F, Shaw, C, Baghbanian, SM, Shuey, N, Onofrj, Marco, Willekens, B, Hardy, TA, Decoo, D, Sempere, AP, Field, D, Wynford-Thomas, R, Cunniffe, NG, Roos, I, Malpas, CB, Coles, AJ, Lugaresi, Alessandra, Kalincik, T, Brown, JWL. Sage; 2023. Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Bateman, Grant Alexander, Lechner-Scott, Jeannette, Carey, Michael Fionn, Bateman, Alexander Robert, Lea, Rodney Arthur. Elsevier; 2021. Possible Markers of Venous Sinus Pressure Elevation in Multiple Sclerosis: Correlations with Gender and Disease Progression.
Field, Judith, Shahijanian, Fernando, Butzkueven, Helmut, Booth, David, Baxter, Alan, Kermode, Allan G., Taylor, Bruce, Booth, David R., Mason, Deborah, Stewart, Graeme J., Butzkueven, Helmut, Charlesworth, Jac, Schibeci, Stephen, Wiley, James, Lechner-Scott, Jeannette, Field, Judith, Tajouri, Lotti, Griffiths, Lyn, Slee, Mark, Brown, Matthew A., Moscato, Pablo, Scott, Rodney J., Broadley, Simon, Johnson, Laura, Vucic, Steve, Kilpatrick, Trevor, Carroll, William M., Gresle, Melissa, Laverick, Louise, Parnell, Grant, Stewart, Graeme, McKay, Fiona, Kilpatrick, Trevor. Public Library of Science (PLOS); 2015. The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function.
Badam, Tejaswi V., Hellberg, Sandra, Berg, Göran, Jenmalm, Maria C., Gustafsson, Mika, Ernerudh, Jan, Mehta, Ratnesh B., Lechner-Scott, Jeannette, Lea, Rodney A., Tost, Jorg, Mariette, Xavier, Svensson-Arvelund, Judit, Nestor, Colm E., Benson, Mikael. Taylor & Francis; 2022. CD4+ T-cell DNA methylation changes during pregnancy significantly correlate with disease-associated methylation changes in autoimmune diseases.
Campagna, Maria Pia, Lechner-Scott, Jeannette, Maltby, Vicki E., Lea, Rodney A., Butzkueven, Helmut, Jokubaitis, Vilija G.. Elsevier; 2023. Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes.
Merlo, Daniel, Stankovich, Jim, Darby, David, Butzkueven, Helmut, Van der Walt, Anneke, Bai, Claire, Kalincik, Tomas, Zhu, Chao, Gresle, Melissa, Lechner-Scott, Jeannette, Kilpatrick, Trevor, Barnett, Michael, Taylor, Bruce. Wolters Kluwer Health; 2021. Association between cognitive trajectories and disability progression in patients with relapsing-remitting multiple sclerosis.
Burnard, Sean M., Lea, Rodney A., Benton, Miles, Eccles, David, Kennedy, Daniel W., Lechner-Scott, Jeannette, Scott, Rodney J.. MDPI AG; 2022. Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models.
Yeh, Wei Z., Van Der Walt, Anneke, Ozakbas, Serkan, Buzzard, Katherine, Habek, Mario, John, Nevin A., Prat, Alexandre, Girard, Marc, Duquette, Pierre, Baghbanian, Seyed Mohammad, Hodgkinson, Suzanne, Van Pesch, Vincent, Skibina, Olga G., Laureys, Guy, Willekens, B, Prevost, J, Foschi, M, De Gans, K, Horakova, D, Havrdova, EK, Karabudak, R, Patti, F, Mccombe, PA, Kalincik, Tomas, Maimone, D, Altintas, A, Ampapa, R, Spitaleri, D, Gerlach, OHH, Sa, MJ, Hughes, S, Gouider, R, Mrabet, S, Macdonell, RA, Alroughani, Raed, Turkoglu, R, Cartechini, E, Al-Asmi, A, Soysal, A, Oh, J, Muros-Le Rouzic, E, Guye, S, Pasquarelli, N, Butzkueven, H, Jokubaitis, VG, Kermode, Allan G., MSBase Study Group,, Fabis-Pedrini, Marzena J., Carroll, William M., Lechner-Scott, Jeannette, Boz, Cavit. Wolters Kluwer Health; 2024. Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.
Roos, Izanne, Hughes, Stella, van der Walt, Anneke, Butzkueven, Helmut, Lechner-Scott, Jeannette, Kuhle, Jens, Terzi, Murat, Laureys, Guy, Van Hijfte, Liesbeth, John, Nevin, Grammond, Pierre, Grand'Maison, Francois, McDonnell, Gavin, Soysal, Aysun, Jensen, AV, Rasmussen, PV, Svendsen, KB, Barzinji, I, Nielsen, HH, Sejbæk, T, Prakash, S, Stilund, MLM, Weglewski, A, Malpas, Charles B., Issa, NM, Kant, M, Sellebjerg, F, Gray, O, Magyari, M, Kalincik, T, MSBase Study GroupDanish MS Registry Study Group,, Sharmin, Sifat, Boz, Cavit, Alroughani, Raed, Ozakbas, Serkan, Buzzard, Katherine, Skibina, Olga. Amercian Medical Association; 2023. Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis.
Groen, Kira, Lea, Rodney A., Maltby, Vicki E., Scott, Rodney J., Lechner-Scott, Jeannette. BioMed Central; 2018. Letter to the editor: blood processing and sample storage have negligible effects on methylation.
Al-iedani, Oun, Arm, Jameen, Ribbons, Karen, Lea, Rodney L., Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2018. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.
Zhu, Chao, Zhou, Zhen, Roos, Izanne, Merlo, Daniel, Kalincik, Tomas, Ozakbas, Serkan, Skibina, Olga, Kuhle, Jens, Hodgkinson, Suzanne, Boz, Cavit, Alroughani, Raed, Lechner-Scott, Jeannette, Barnett, Michael, Izquierdo, Guillermo, Prat, Alexandre, Horakova, Dana, Havrdova, Eva Kubala, Macdonell, Richard, Patti, Francesco, Khoury, Samia Joseph. BMJ Group; 2022. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.
Le, Minh, Malpas, Charles, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Larochelle, Catherine, Alroughani, Raed, Bergamaschi, Roberto, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Grand’ Maison, Francois, Sharmin, Sifat, Lechner-Scott, Jeannette, Boz, C, Hupperts, R, Butzkueven, H, Pucci, E, Granella, F, Van Pesch, V, Soysal, A, Yamout, BI, Lechner-Scott, J, Horáková, Dana, Spitaleri, DLA, Ampapa, R, Turkoglu, R, Iuliano, G, Ramo-Tello, C, Sanchez-Menoyo, JL, Sidhom, Y, Gouider, R, Shaygannejad, V, Prevost, J, Havrdova, Eva, Altintas, A, Fragoso, YD, McCombe, PA, Petersen, T, Slee, M, Barnett, MH, Vucic, S, Van Der Walt, A, Kalincik, T, Trojano, Maria, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Lugaresi, Alessandra. Sage Publications; 2021. Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Wang, Joanne H., Pappas, Derek, Hauser, Stephen L., Baranzini, Sergio E., Oksenberg, Jorge R., Bahlo, Melanie, Booth, David R., Broadley, Simon A., Brown, Matthew A., Foote, Simon J., Griffiths, Lyn R., Kilpatrick, Trevor J., De Jager, Philip L., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Danoy, Patrick, Pelletier, Daniel, Butzkueven, Helmut, Slee, Mark, Greer, Judith, Kermode, Allan, Carroll, William, de Bakker, Paul I., Kappos, Ludwig, Polman, Chris H., Chibnik, Lori B., Hafler, David A., Matthews, Paul M.. BioMed Central; 2011. Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
Ramanathan, Sudarshini, Mohammad, Shekeeb, Henderson, Andrew P. D., Barnett, Michael Harry, Reddel, Stephen W., Brilot, Fabienne, Dale, Russell C., Tantsis, Esther, Nguyen, Tina Kim, Merheb, Vera, Fung, Victor S. C., White, Owen Bruce, Broadley, Simon, Lechner-Scott, Jeannette, Vucic, Steve. British Medical Journal (BMJ); 2018. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
Alshehri, Abdulaziz, Al-Iedani, Oun, Arm, Jameen, Gholizadeh, Neda, Billiet, Thibo, Lea, Rodney, Lechner-Scott, Jeannette, Ramadan, Saadallah. Sage Publications; 2022. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
Kalincik, Tomas, Manouchehrinia, Ali, Girard, Marc, Prat, Alexandre, Duquette, Pierre, Grammond, Pierre, Sola, Patrizia, Hupperts, Raymond, Grand'Maison, Francois, Pucci, Eugenio, Boz, Cavit, Alroughani, Raed, Sobisek, Lukas, Lechner-Scott, Jeannette, , , , , , , , , , Jokubaitis, Vilija, , , , , , , , , , , Spelman, Tim, , , , , , , , Horakova, Dana, Havrdova, Eva, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra. Oxford University Press; 2017. Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Maltby, Vicki E., Lea, Rodney A., Ribbons, Karen A., Sanders, Katherine A., Kennedy, Daniel, Min, Myintzu, Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2018. DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate.
Spelman, Timothy, Kalincik, Tomas, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Zhang, Annie, Trojano, Maria, Butzkueven, Helmut, , Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek. John Wiley & Sons; 2015. Comparative efficacy of switching to natalizumab in active multiple sclerosis.
Malhotra, Sunny, Sorosina, Melissa, Zettl, Uwe K., Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Comi, Giancarlo, Montalban, Xavier, Martinelli-Boneschi, Filippo, Comabella, Manuel, Río, Jordi, Peroni, Silvia, Midaglia, Luciana, Villar, Luisa M., Álvarez-Cermeño, Jose C., Schroeder, Ina, Esposito, Federica, Clarelli, Ferdinando. Sage; 2018. NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.
Bukhari, Wajih, Clarke, Laura, Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brownlee, Wallace, Butzkueven, Helmut, Carroll, William M., Chen, Celia, O'Gorman, Cullen, Coulthard, Alan, Dale, RC, Das, C, Dear, K, Fabis-Pedrini, MJ, Fulcher, D, Gillis, D, Hawke, S, Heard, R, Henderson, APD, Khalilidehkordi, Elham, Heshmat, S, Hodgkinson, S, Jimenez-Sanchez, S, Kilpatrick, TJ, King, J, Kneebone, C, Kornberg, AJ, Lechner-Scott, Jeannette, Lin, MW, Lynch, C, Arnett, Simon, Macdonnell, RAL, Mason, DF, McCombe, PA, Pereira, J, Pollard, JD, Reddel, SW, Shaw, C, Spies, J, Stankovich, J, Sutton, I, Prain, Kerri M., Vucic, S, Walsh, M, Wong, RC, Yiu, EM, Barnett, MH, Kermode, AG, Marriott, MP, Parratt, J, Slee, M, Taylor, BV, Woodhall, Mark, Willoughby, E, Wilson, RJ, Brilot, F, Vincent, A, Waters, P, Broadley, SA, Silvestrini, Roger, Bundell, Christine S., Ramanathan, Sudarshini. Springer; 2020. The clinical profile of NMOSD in Australia and New Zealand.
Patsopoulos, Nikolaos A., de Bakker, Paul I. W., Kappos, Ludwig, Miller, David, Montalbán, Javier, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Arnason, Barry G. W., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Esposito, Federica, Goodin, Douglas S., Jeffery, Douglas, O'Connor, Paul, Ebers, George C., Langdon, Dawn, Reder, Anthony T., Traboulsee, Anthony, Zipp, Frauke, Schimrigk, Sebastian, Hillert, Jan, Reischl, Joachim, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Foote, Simon J., Lehr, Stephan, Griffiths, Lyn, Kermode, Allan G., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Heard, Robert N., Pender, Michael P., Perreau, Victoria M., Bauer, David, Perera, Devindri, Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Tubridy, Niall, Willoughby, Ernest, Wiley, James, Heubach, Jürgen, Matthews, Paul, Boneschi, Filippo M., Compston, Alastair, Haines, Jonathan, Hauser, Stephen L., McCauley, Jacob, Ivinson, Adrian, Oksenberg, Jorge R., Pericak-Vance, Margaret, Sawcer, Stephen J., Sandbrink, Rupert, De Jager, Philip L., Hafler, David A., Pohl, Christoph, Edan, Gilles. John Wiley & Sons; 2011. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Al-iedani, Oun, Lea, Stasson, Alshehri, A., Maltby, Vicki E., Saugbjerg, Bente, Ramadan, Saadallah, Lea, Rodney, Lechner-Scott, Jeannette. Elsevier; 2024. Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study..
Maltby, Vicki E., Lea, Rodney A., Ribbons, Karen, Lea, Marino G., Schofield, Peter W., Lechner-Scott, Jeannette. Elsevier; 2020. Comparison of BICAMS and ARCS for assessment of cognition in multiple sclerosis and predictive value of employment status.
Peroni, Silvia, Sorosina, Melissa, Álvarez-Cermeño, José Carlos, Guaschino, Clara, Radaelli, Marta, Citterio, Lorena, Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Martinelli, Vittorio, Montalban, Xavier, Weiner, Howard L., Malhotra, Sunny, de Jager, Philip, Comi, G, Esposito, F, Comabella, M, Martinelli-Boneschi, F, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferrè, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luis Maria. Sage; 2020. A pharmacogenetic study implicates NINJ2 in the response to Interferon-ß in multiple sclerosis.
Lizak, Nathaniel, Lugaresi, Alessandra, Girard, Marc, Prat, Alexandre, Grammond, Pierre, Hupperts, Raymond, Grand'Maison, Francois, Sola, Patrizia, Pucci, Eugenio, Bergamaschi, Roberto, Oreja-Guevara, Celia, Van Pesch, Vincent, Alroughani, Raed, , , , , , , , , , , Lechner-Scott, Jeannette, , , , , , , , Slee, Mark, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre. BMJ Group; 2017. Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, , , Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond. Sage; 2014. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
Lizak, Nathaniel, Hodgkinson, Suzanne, Butler, Ernest, Lechner-Scott, Jeannette, Slee, Mark, McCombe, Pamela Ann, Shaw, Cameron, Skibina, Olga, Vucic, Steve, Shuey, Neil, Barnett, Michael H., Parratt, John, Butzkueven, Helmut, Jack, Dominic, Fabris, Jessica, Kalincik, Tomas. Sage; 2021. Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: an MSBase registry substudy.
Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo. Sage; 2020. Risk of secondary progressive multiple sclerosis: a longitudinal study.
Kreiter, Daniel, Kalincik, Tomas, Lechner-Scott, Jeannette, Ozakbas, Serkan, Gerlach, Ozakbas, Turkoglu, R., Soysal, A., Boz, C., Al-Asmi, A., Alkhaboori, J., Amato, M. P., Onofrj, M., Hupperts, Raymond, Lugaresi, A., Besora, S, Sanchez-Menoyo, JL, Lapointe, E, Grand’Maison, F, Grammond, P, Butzkueven, H, Van der Walt, A, Taylor, BV, McCombe, PA, Patti, Francesco, Garber, JY, Skibina, OG, Buzzard, KA, John, NA, Shaw, C, Barnett, MH, Spitaleri, Daniele, Foschi, Matteo, Surcinelli, Andrea, Maimone, Davide, Yamout, Bassem, Khoury, Samia J.. Adis International; 2024. Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study.
Jameen, A. R. M., Al-iedani, Oun, Ribbons, Karen, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. Wiley-Blackwell Publishing; 2021. Biochemical Correlations with Fatigue in Multiple Sclerosis Detected by MR 2D Localized Correlated Spectroscopy.
Kalincik, Tomas, Spelman, Timothy, Grand’Maison, Francois, La Spitaleri, Daniele, Rio, Maria Edite, Flechter, Sholmo, Oreja-Guevara, Celia, Giuliani, Giorgio, Savino, Aldo, Amato, Maria Pia, Petersen, Thor, Fernandez-Bolanos, Ricardo, Trojano, Maria, Bergamaschi, Roberto, Iuliano, Gerardo, Boz, Cavit, Lechner-Scott, Jeannette, Duquette, Pierre, Izquierdo, Guillermo, Grammond, Pierre, Lugaresi, Alessandra, Hupperts, Raymond, Cristiano, Edgardo, Van Pesch, Vincent. Public Library of Science; 2013. Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Groen, Kira, Maltby, Vicki E., Scott, Rodney J., Tajouri, Lotti, Lechner-Scott, Jeannette. Elsevier; 2020. Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls.
Hughes, Stella E., Spelman, Tim, Grammond, Pierre, Oreja-Guevara, Celia, Hupperts, Raymond, Bergamaschi, Roberto, Giuliani, Giorgio, Lechner-Scott, Jeannette, Barnett, Michael, Edite Rio, Maria, Van Pesch, Vincent, Amato, Maria Pia, Gray, Orla M., Iuliano, Gerardo, Slee, Mark, Verheul, Freek, Cristiano, Edgardo, Fernández-Bolaños, Ricardo, Poehlau, Dieter, Saladino, Maria Laura, Deri, Norma, Cabrera-Gomez, Jose, Vella, Norbert, Boz, Cavit, Herbert, Joseph, Skromne, Eli, Savino, Aldo, Shaw, Cameron, Moore, Fraser, Vucic, Steve, Petkovska-Boskova, Tatjana, McDonnell, Gavin, Hawkins, Stanley, Kee, Frank, Trojano, Maria, Butzkueven, Helmut, Lugaresi, Alessandra, Izquierdo, Guillermo, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois. Sage; 2014. Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Tao, Chunrong, Simpson, Steve, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, van der Mei, Ingrid, Lechner-Scott, Jeannette, Van Pesch, Vincent, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, Spitaleri, Daniele L. A., Slee, Mark, Verheul, Freek, Blizzard, Leigh, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Havrdova, Eva, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V., Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria. BMJ Group; 2016. Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
Maltby, Vicki E., Lea, Rodney A., Graves, Moira C., Sanders, Katherine A., Benton, Miles C., Tajouri, Lotti, Scott, Rodney J., Lechner-Scott, Jeannette. Nature Publishing Group; 2018. Genome-wide DNA methylation changes in CD19⁺ B cells from relapsing-remitting multiple sclerosis patients.
Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette. Sage; 2014. Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
Li, Ying, Saul, Alice, Eichau, Sara, Onofrj, Marco, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva Kubala, Grand'Maison, Francois, Alroughani, Raed, Gerlach, Oliver, Amato, Maria Pia, Altintas, Ayse, Taylor, Bruce, Girard, M, Duquette, P, Blanco, Y, Ramo-Tello, C, Laureys, G, Kalincik, T, Khoury, SJ, Shaygannejad, V, Etemadifar, M, Singhal, B, Ponsonby, Anne-Louise, Mrabet, S, Foschi, M, Habek, M, John, N, Hughes, S, McCombe, P, Ampapa, R, van der Walt, A, Butzkueven, H, de Gans, K, Simpson-Yap, Steve, McGuigan, C, Oreja-Guevara, C, Sa, MJ, Petersen, T, Al-Harbi, T, Sempere, AP, Van Wijmeersch, B, Grigoriadis, N, Prevost, J, Gray, O, Blizzard, Leigh, Castillo-Trivino, T, Macdonell, R, Lugaresi, A, Sajedi, SA, van der Mei, I, Broadley, Simon, Lechner-Scott, Jeannette, Karabudak, Rana, Patti, Francesco. Springer; 2024. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
Arm, Jameen, Al-Iedani, Oun, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. John Wiley & Sons; 2019. Diurnal variability of cerebral metabolites in healthy human brain with two-dimensional localised correlation spectroscopy (2D L-COSY).
Sharmin, Sifat, Lefort, Mathilde, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand'Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Andersen, Johanna Balslev, Trojano, Maria, McCombe, P, Slee, M, Lechner-Scott, Jeannette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Leray, Emmanuelle, Skibina, O, Buzzard, K, Van der Walt, A, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Horakova, Dana, Ciron, J, Ruet, A, De Seze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Havrdova, Eva Kubala, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Alroughani, Raed, Montcuquet, A, Wahab, A, Camdessanche, J-P, Maurousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Izquierdo, Guillermo, Laplaud, D, Koch-Henriksen, N, Sellebjerg, FT, Soerensen, PS, Pfleger, CC, Rasmussen, PV, Jensen, MB, Frederiksen, JL, Bramow, S, Mathiesen, HK, Ozakbas, Serkan, Schreiber, KI, Magyari, M, Vukusic, S, Butzkueven, H, Kalincik, T, Patti, Francesco. Adis International; 2021. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Solomon, Andrew J., Arrambide, Georgina, Fujihara, Kazuo, Graves, Jennifer, Harnegie, Mary Pat, Hemmer, Bernhard, Lechner-Scott, Jeannette, Marrie, Ruth Ann, Newsome, Scott D., Rocca, Maria A., Royal, Walter, Waubant, Emmanuelle L., Brownlee, Wallace J., Yamout, Bassem, Cohen, JA, Flanagan, Eoin P., Amato, Maria Pia, Amezcua, Lilyana, Banwell, Brenda L., Barkhof, Frederik, Corboy, John R., Correale, Jorge. Lancet Publishing Group; 2023. Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Kister, Ilya, Chamot, Eric, Duquette, Pierre, Lugaresi, Alessandra, Grammond, Pierre, Boz, Cavit, Hupperts, Raymond, Petersen, Thor, Giuliani, Giorgio, Oreja-Guevara, Celia, Iuliano, Gerardo, Lechner-Scott, Jeannette, Cutter, Gary, , , , , , , , , , Bacon, Tamar E., Jokubaitis, Vilija G., Hughes, Stella E., Gray, Orla M., Trojano, Maria, Izquierdo, Guillermo, Grand'Maison, Francois. Elsevier; 2012. Increasing age at disability milestones among MS patients in the MSBase Registry.
Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep. BMJ Group; 2017. Incidence and prevalence of NMOSD in Australia and New Zealand.
Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.. Elsevier; 2014. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies.
Maltby, Vicki, Xavier, Alexandre, Slee, Mark, van der Mei, Ingrid A., Taylor, Bruce V., Ponsonby, Anne-Louise, Jagodic, Maja, Lea, Rodney, Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria-Pia, Sampangi, Sandeep, Scott, Rodney J., Butzkueven, Helmut, Jokubaitis, Vilija, Kular, Lara, Bos, Steffan. Wolters Kluwer; 2023. Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis.
De Brouwer, Edward, Becker, Thijs, Kappos, Ludwig, Sola, Patrizia, Cartechini, Elisabetta, Lechner-Scott, Jeannette, Alroughani, Raed, Gerlach, Oliver, Kalincik, Tomas, Granella, Franco, Grand'Maison, Francois, Bergamaschi, Roberto, Moreau, Yves, José Sá, M, Van Wijmeersch, B, Soysal, A, Sanchez-Menoyo, JL, Solaro, C, Boz, C, Iuliano, G, Buzzard, K, Aguera-Morales, E, Terzi, M, Havrdova, Eva Kubala, Trivio, TC, Spitaleri, D, Van Pesch, V, Shaygannejad, V, Moore, F, Oreja-Guevara, C, Maimone, D, Gouider, R, Csepany, T, Ramo-Tello, C, Trojano, Maria, Peeters, L, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Grammond, Pierre, Kuhle, Jens. Elsevier; 2021. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.
Al-iedani, Oun, Lechner-Scott, Jeannette, Ribbons, Karen, Ramadan, Saadallah. BioMed Central; 2017. Fast magnetic resonance spectroscopic imaging techniques in human brain-applications in multiple sclerosis.
Kister, Ilya, Spelman, Tim, Grand'Maison, Francois, Alroughani, Raed, Terzi, Murat, Boz, Cavit, Hupperts, Raymond, Lechner-Scott, Jeannette, Kappos, Ludwig, Pucci, Eugenio, Hodgkinson, Suzanne, Solaro, Claudio, Patti, Francesco, Butzkueven, Helmut, Duquette, Pierre, Trojano, Maria, Izquierdo, Guillermo, Lugaresi, Alessandra, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana. Elsevier; 2018. Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.